scholarly journals Overview of Sleep and Circadian Rhythm Disorders in Parkinson Disease

2020 ◽  
Vol 36 (1) ◽  
pp. 119-130 ◽  
Author(s):  
Priti Gros ◽  
Aleksandar Videnovic
2021 ◽  
Vol 19 (2) ◽  
pp. 34-38
Author(s):  
A. S. SAMOYLOV ◽  
◽  
N. V. RYLOVA ◽  
A. V. ZHOLINSKIY ◽  
I. V. BOLSHAKOV ◽  
...  

The article presents data from the Russian and foreign literature of the properties of melatonin, its role in the vital activity of the body and the regulation of circadian rhythms. The features of using the drug in desynchronosis, the optimal dosage and time of administration, as well as the possibility of its use in combination with non-pharmacological treatment methods are discussed. These methods include dosed light exposure and exercise. Additionally, new studies are considered, indicating the beneficial effect of melatonin and its agonists on the immune, cardiovascular, endocrine and nervous systems. Based on the collected data, it is asserted that melatonin can significantly accelerate the process of adaptation to a new time zone without the development of side effects. Therefore, this drug is the most effective and safe treatment for desynchronosis. It is also important to note that the study of the multifaceted effects of melatonin on body functions opens up great prospects in the treatment of many diseases.


Engrami ◽  
2020 ◽  
Vol 42 (2) ◽  
pp. 57-68
Author(s):  
Nikola Trajanović

A novel group of medications, dual orexin receptor antagonists, emerged as a competent group that challenges current first-line hypnotics. They have relatively infrequent and mostly well-tolerated side effects, primarily in the form of residual somnolence, fatigue and nightmares/disturbing dreams. The advantage over conventional hypnotics stems from the specifics of their target receptors, which translates into lack of tolerance after long term use and good safety profile. They are particularly favoured in some specific populations, including the elderly. Ongoing and future studies are set to explore their effect on selected conditions, such as addiction and psychiatric disorders, dementias, perimenopausal condition and circadian rhythm disorders, to name a few.


1999 ◽  
Vol 53 (2) ◽  
pp. 267-268 ◽  
Author(s):  
Mikako Yazaki ◽  
Shuichiro Shirakawa ◽  
Masako Okawa ◽  
Kiyohisa Takahashi

Author(s):  
Tracey L. Sletten ◽  
Josephine Arendt

2015 ◽  
Vol 104 (4) ◽  
pp. 710-716
Author(s):  
Masaya Yamaoka ◽  
Iichiro Shimomura

Sign in / Sign up

Export Citation Format

Share Document